Before You Begin
Question #44579
The Question
Consider the following three mononuclear coordination complexes: (I) \ce{[Pt(gly)2]} (II) \ce{[Zn(gly)2]} (III) \ce{[Co(en)2Cl2]+} (where gly = glycinato, en = ethylenediamine)
Assume all complexes exhibit their ideal, characteristic coordination geometries without any solvent coordination. Let represent the total number of stereoisomers and represent the number of enantiomeric pairs for a given complex. Which of the following options correctly lists the values of for complexes (I), (II), and (III) respectively?
Options
- A.
(I): (2, 0); (II): (2, 1); (III): (3, 1)
- B.
(I): (2, 0); (II): (1, 0); (III): (3, 1)
- C.
(I): (3, 1); (II): (2, 1); (III): (4, 1)
- D.
(I): (2, 0); (II): (2, 0); (III): (3, 1)
Check Your Answer
Correct Answer
Step-by-Step Solution
Explanation
How the Examiner Thinks
Exception_Exposure
Learn to identify edge cases and boundary exceptions that JEE examiners hide in math problems.
Concepts Behind This Question
Optical Isomerism Logic|Geometric Isomerism Requirements|Oxidation State Traps
Why This Question Is Tricky
Common Mistakes
This question tests the student's ability to move beyond rote memorization of optical isomerism rules.
The primary trap lies in Complex (II), \ce{[Zn(gly)2]}.
Students often falsely assume that tetrahedral complexes are only chiral if all four ligands are different, or they memorize that bis-chelate complexes are only chiral in octahedral \textit{cis} geometries.
By forcing them to evaluate the symmetry of a tetrahedral complex, the question reveals that the unsymmetrical bidentate ligand breaks the improper axis of rotation present in , rendering the molecule chiral ( symmetry).
Additionally, it tests the fundamental assignment of coordination geometries based on periodic trends ( vs ).
Quick Facts About This Question
Question Information
| Subject | Chemistry |
| Chapter | Coordination Compounds - Class 12 |
| Concept | Optical Isomerism Logic |
| Difficulty | 8 |
| Cognitive Load | 7 |
| Target Solve Time | 160 sec |
| Access | Free |